Trial Profile
A phase II/III, observer-blind, randomised, active controlled study to compare the safety and immunogenicity of a meningococcal A conjugate vaccine (PsA-TT) with meningococcal ACWY polysaccharide vaccine administered in healthy children 2 to 10 years of age.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Mar 2020
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group A conjugate (Primary) ; Meningococcal vaccine groups A C Y W-135 polysaccharide
- Indications Bacterial meningitis; Meningococcal group A infections; Meningococcal infections
- Focus Pharmacodynamics
- Sponsors Serum Institute of India
- 12 Jan 2012 New trial record